Delcath Systems, Inc. Profile Avatar - Palmy Investing

Delcath Systems, Inc.

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery s…

Medical - Specialties
US, New York [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
End of DCTH's Analysis
CIK: 872912 CUSIP: 24661P807 ISIN: US24661P8077 LEI: - UEI: -
Secondary Listings
DCTH has no secondary listings inside our databases.